PubRank

L M Matrisian

Author PubWeight™ 154.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999 6.49
2 Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997 5.07
3 Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001 4.99
4 Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000 4.98
5 Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A 1997 3.96
6 The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999 3.95
7 Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 1985 3.60
8 Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001 3.51
9 Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 1986 2.74
10 Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996 2.50
11 Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000 2.44
12 Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A 1994 2.43
13 The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 2000 2.42
14 Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000 2.39
15 The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci U S A 1986 2.28
16 Structure-function relationships in the collagenase family member transin. J Biol Chem 1988 2.15
17 Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 2001 2.12
18 Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 1996 2.12
19 TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 1990 2.09
20 Epidermal growth factor or serum stimulation of rat fibroblasts induces an elevation in mRNA levels for lactate dehydrogenase and other glycolytic enzymes. Nucleic Acids Res 1985 2.08
21 Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 1988 2.05
22 Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995 1.96
23 Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991 1.95
24 Matrilysin expression and function in airway epithelium. J Clin Invest 1998 1.94
25 Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1995 1.93
26 Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994 1.92
27 Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994 1.83
28 Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994 1.80
29 Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number. J Biol Chem 1980 1.65
30 Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 1990 1.63
31 The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res 1998 1.60
32 The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell 1995 1.60
33 Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994 1.55
34 Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 1997 1.50
35 Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 2000 1.49
36 The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 2001 1.48
37 Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996 1.45
38 Further purification of epidermal growth factor by high-performance liquid chromatography. Anal Biochem 1982 1.42
39 Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell 2001 1.40
40 Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997 1.40
41 The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem 1992 1.34
42 Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2002 1.33
43 A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog 1997 1.27
44 Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 1993 1.26
45 TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 2000 1.24
46 Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcinog 1999 1.23
47 Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1995 1.23
48 EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 1991 1.22
49 Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 1990 1.22
50 Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res 1998 1.22
51 Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis. Cancer Res 1995 1.18
52 Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997 1.18
53 Tumor progression: defining the soil round the tumor seed. Curr Biol 2001 1.17
54 Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res 1987 1.17
55 Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 1995 1.13
56 Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch". J Biol Chem 1991 1.12
57 Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts. Proc Natl Acad Sci U S A 1984 1.10
58 Stromelysin in tumor progression and metastasis. Cancer Metastasis Rev 1990 1.07
59 Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 1992 1.05
60 Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Int J Cancer 1998 1.05
61 Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A 1994 1.03
62 A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog 1994 1.01
63 Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. J Biol Chem 1988 1.01
64 Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1998 1.00
65 Complex roles of matrix metalloproteinases in tumor progression. Curr Top Microbiol Immunol 1996 1.00
66 Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol Biol Cell 1998 0.99
67 Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts. J Mol Cell Cardiol 2006 0.98
68 Binding of epidermal growth factor in rat pancreatic acini. Biochem Biophys Res Commun 1983 0.95
69 Matrilysin in early stage intestinal tumorigenesis. APMIS 1999 0.95
70 Mechanism of synergistic induction of DNA synthesis by epidermal growth factor and tumor promoters. J Cell Physiol 1981 0.93
71 Effect of epidermal growth factor on clonogenic growth of primary human tumor cells. Int J Cancer 1982 0.93
72 Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors. Mol Cell Biol 2001 0.92
73 Matrilysin expression in the involuting rat ventral prostate. Prostate 1996 0.92
74 Stabilized beta-catenin immortalizes colonic epithelial cells. Cancer Res 2001 0.92
75 Intracellular processing of epidermal growth factor. I. Acidification of 125I-epidermal growth factor in intracellular organelles. J Biol Chem 1984 0.90
76 A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells. J Biol Chem 1995 0.89
77 Identification of an epidermal growth factor-related transforming growth factor from rat fetuses. Biochem Biophys Res Commun 1982 0.89
78 Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res 1996 0.88
79 Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog 2005 0.87
80 Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells. Cancer Res 1981 0.87
81 Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod 1998 0.86
82 Tumor promoters induce a transient expression of tumor-associated genes in both basal and differentiated cells of the mouse epidermis. Carcinogenesis 1988 0.86
83 Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Res 1997 0.86
84 Matrix degrading metalloproteinases. J Neurooncol 1994 0.86
85 The role of C-Fos in growth factor regulation of stromelysin/transin gene expression. Matrix Suppl 1992 0.85
86 Binding, internalization and intracellular processing of 125I-epidermal growth factor purified by isoelectric focusing. Biochem Biophys Res Commun 1982 0.84
87 Altered regulation of protein disulfide isomerase in cells resistant to the growth-inhibitory effects of transforming growth factor beta 1. Cell Growth Differ 1990 0.82
88 Expression and regulation of stromelysin and matrilysin by growth factors and oncogenes. Biochem Soc Trans 1994 0.81
89 Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Curr Opin Oncol 2001 0.81
90 Internalization and processing of epidermal growth factor in aging human fibroblasts in culture. Exp Gerontol 1987 0.80
91 The protease consortium: an alliance to advance the understanding of proteolytic enzymes as therapeutic targets for cancer. Mol Carcinog 1999 0.80
92 Direct modulation of epidermal growth factor binding by cholecystokinin. Life Sci 1983 0.80
93 Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes. J Cell Sci 2000 0.80
94 Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction. Br J Cancer 2003 0.80
95 Role of transforming growth factor-beta and epidermal growth factor in the wound-healing process: an in vivo biomechanical evaluation. Wound Repair Regen 1993 0.79
96 Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res 2000 0.78
97 Disruption of intracellular processing of epidermal growth factor by methylamine inhibits epidermal growth factor-induced DNA synthesis but not early morphological or transcriptional events. J Biol Chem 1987 0.78
98 Protein kinase C isotypes required for phorbol-ester induction of stromelysin-1 in rat fibroblasts. Mol Carcinog 1996 0.78
99 Effect of maturation on gastrointestinal absorption of epidermal growth factor in rats. Am J Physiol 1987 0.78
100 Processing of epidermal growth factor by suckling and adult rat intestinal cells. Am J Physiol 1986 0.77
101 Epidermal growth factor binding is altered in pancreatic acini from diabetic rats. Life Sci 1984 0.77
102 Interaction of tumor promoters and growth factors with cultured cells. Carcinog Compr Surv 1982 0.75
103 Effect of retinoic acid on the late-stage promotion of transformation in JB6 mouse epidermal cells in culture. Cancer Res 1985 0.75
104 Heterogeneity of 125I-labeled epidermal growth factor. Biochim Biophys Acta 1985 0.75
105 Differential effects of lysosomotropic amines and polyamines on processing and biological activity of EGF. Exp Cell Res 1984 0.75
106 Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-->q22. Cytogenet Cell Genet 1996 0.75
107 Developing in a family way. Transforming Growth Factor Type beta and Related Proteins in Development: the Sixth Molecular, Cellular and Developmental Biology/Iowa State University Symposium, Ames, IA, USA September 20-23, 1991. New Biol 1992 0.75